Literature DB >> 3126145

The availability of purines influences both the number of parasites and the splenocyte levels of purine-metabolizing enzymes in trypanosome-infected mice.

J W Albright1, J F Albright.   

Abstract

Growth on Trypanosoma musculi in the murine host was limited by the availability of host purines. A portion of the spleen cells of infected mice (many of them granulocytes) displayed high levels of adenosine deaminase (ADA) and purine nucleoside phosphorylase, probably as a compensatory response to extracellular purine deficiency. Injections of adenosine or 2-deoxycoformycin stimulated significant increases in the growth of parasites. 2-Deoxycoformycin treatment also diminished parasite-induced splenomegaly. Treatment of mice with polyethylene glycol-modified ADA, a slowly catabolized form of ADA, had no effect on the course of T. musculi infection, indicating that the parasites can utilize purines other than adenosine. The apparent competition between parasites and host cells for available purines suggests that depletion of extracellular purines should be considered as an approach to treating extracellular trypanosome infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126145      PMCID: PMC259377          DOI: 10.1128/iai.56.4.831-835.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Ectoenzyme action on purine nucleotides in macrophages and subsequent reactions.

Authors:  M L Karnovsky; M M Philippeaux
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

2.  Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites.

Authors:  J D Schwartzman; E R Pfefferkorn
Journal:  Exp Parasitol       Date:  1982-02       Impact factor: 2.011

3.  Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides.

Authors:  J D Pearson; J L Gordon
Journal:  Nature       Date:  1979-10-04       Impact factor: 49.962

4.  Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.

Authors:  T S Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. II. Evaluation of human sera.

Authors:  R A Hartwick; A M Krstulovic; P R Brown
Journal:  J Chromatogr       Date:  1979-12-30

6.  Uptake of purine bases and nucleosides in African trypanosomes.

Authors:  D M James; G V Born
Journal:  Parasitology       Date:  1980-10       Impact factor: 3.234

7.  Differences in resistance to Trypanosoma musculi infection among strains of inbred mice.

Authors:  J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Histopathological and immunocytochemical studies of Trypanosoma musculi infection of mice.

Authors:  K Hirokawa; Y Eishi; J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol.

Authors:  S Davis; A Abuchowski; Y K Park; F F Davis
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

10.  Inhibition of murine humoral immune responses by substances derived from trypanosomes.

Authors:  J W Albright; J F Albright
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

View more
  2 in total

1.  Immunological and nonimmunological control of severity of Trypanosoma musculi infections in C3H and C57BL/6 inbred mice.

Authors:  J W Albright; J F Albright
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Immune and nonimmune regulation of the population of Trypanosoma musculi in infected host mice.

Authors:  J W Albright; M Pierantoni; J F Albright
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.